FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,117 letters match. Newest first.

  1. Global Pharma Healthcare Private Limited

    FDA warned Global Pharma Healthcare that non-sterile artificial tears and eye ointment from its India plant were tied to a Pseudomonas outbreak with four deaths.

    High risk
  2. Natural Relief Inc.

    Natural Relief Inc. of Coshocton, Ohio, sold two herbal capsule products as unapproved drugs and had serious supplement manufacturing violations.

    High risk
  3. Ming Fai Industrial Co LTD

    Ming Fai Industrial, a Shenzhen device maker, lacked validation and acceptance-status controls for ultrasound gel and probe covers.

    High risk
  4. Acrostak Schweiz AG

    FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.

    High risk
  5. ADM Animal Nutrition

    FDA warned ADM Animal Nutrition that insufficient hazard controls let excess vitamin D into dog food preblend.

    High risk
  6. InnoMark, Inc.

    FDA warned InnoMark, Inc. about dietary supplements made under poor manufacturing conditions and with misleading labels after a March 2023 inspection.

    High risk
  7. ALI Pharmaceutical Manufacturing, LLC

    FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.

    High risk
  8. Suther Feeds, Inc.

    Suther Feeds made super-potent monensin cattle feed linked to numerous cattle deaths and recalled it.

    High risk
  9. Handock Cosmetics Co., Ltd.

    FDA warns Handock Cosmetics over manufacturing quality failures and unapproved/mislabeled hand sanitizers from South Korea.

    High risk
  10. Sun Pharmaceutical Industries Ltd.

    FDA warns Sun Pharmaceutical over CGMP violations in sterile injectable manufacturing at its Halol, India facility.

    High risk
  11. Seoul Cosmetics Co., Ltd.

    FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.

    High risk
  12. Fanta Seafoods

    FDA warned Fanta Seafoods that serious seafood safety plan (HACCP) and sanitation failures at its Guyana plant made mackerel and shrimp adulterated.

    High risk
  13. Abiomed Inc.

    Abiomed marketed Impella Connect System without PMA and had CGMP, complaint, and MDR reporting failures.

    High risk
  14. Signature Biologics, LLC

    FDA cited Signature Biologics for unapproved, unlicensed Signature Cord and serious sterile manufacturing failures.

    High risk
  15. Fresenius Kabi AG

    FDA warned Fresenius Kabi’s Fenwal plant in Puerto Rico about unsafe manufacturing of blood-pack units and solutions.

    High risk
  16. Oceanitan, Inc.

    Oceanitan's refrigerated ready-to-eat baby food, tied to an infant botulism complaint, was made with botulinum hazards uncontrolled and insanitary conditions.

    High risk
  17. PT. Winson Prima Sejahtera

    FDA says PT. Winson Prima Sejahtera's ready-to-eat yellowfin tuna seafood safety plan lacks pathogen and histamine controls.

    High risk
  18. Kor-Chem, Inc.

    Kor-Chem, Inc. made OTC hand sanitizer drugs with manufacturing violations, including shared equipment with industrial chemicals and missing identity and microbial testing.

    High risk
  19. PureChemPros LLC

    FDA warns PureChemPros over manufacturing quality failures and unapproved, misbranded hand sanitizer and hydrogen peroxide drugs.

    High risk
  20. Moorish Science Temple, The Divine and National Movement of North America, Inc; #13 The Moorish American National Republic dba Moor Herbs, Inc.

    FDA warned Moor Herbs that its herbal products are unapproved drugs with disease claims and are made without required supplement quality controls.

    High risk
  21. CVS Health

    FDA told CVS Health its unapproved Pink Eye Relief Drops are an illegal new drug made by a manufacturer with serious quality violations.

    High risk
  22. TRP Company, Inc

    FDA warns TRP Company that its homeopathic eye drops and ointments are unapproved new drugs and may be adulterated.

    High risk
  23. Walgreens Boots Alliance, Inc.

    FDA warned Walgreens over three store-brand eye drops sold as unapproved new drugs and tied to contract manufacturer manufacturing violations.

    High risk
  24. Similasan AG

    Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.

    High risk
  25. BYD Precision Manufacture Co., Ltd

    FDA warned BYD Precision Manufacture over quality-system and reporting failures for surgical masks and an N95 respirator made in Shenzhen, China.

    Medium
  26. Safecor Health, LLC

    FDA warned drug repackager Safecor Health over CGMP failures that let tablets from other drugs contaminate packaging lines.

    High risk
  27. Caltag Medsystems Ltd

    FDA warned Caltag Medsystems over quality-system failures in making TransFix/EDTA Vacuum Blood Collection Tubes.

    Medium
  28. Green Pharmaceutical Co. Ltd.

    FDA warns South Korea's Green Pharmaceutical over OTC drug CGMP failures, including missing identity testing and weak quality unit.

    High risk
  29. Osmosis, LLC

    Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.

    High risk
  30. Lex Inc.

    FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.

    High risk
  31. Reckitt/Mead Johnson Nutrition

    FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.

    High risk
  32. ByHeart, Inc.

    FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.

    High risk
  33. Perrigo Wisconsin, LLC

    FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.

    High risk
  34. Gadal Laboratories Inc.

    FDA warned Gadal Laboratories of CGMP violations at its Miami drug plant, including unqualified suppliers and contamination risks in pediatric OTC drugs.

    High risk
  35. Cosmobeauti Laboratories & Manufacturing Inc.

    FDA warns Cosmobeauti Laboratories over manufacturing rule violations for OTC sunscreen drugs, including backdated batch records and missing microbial testing.

    High risk
  36. K.C. Pharmaceuticals Inc.

    FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.

    High risk
  37. Amor Nino Foods, Inc.

    FDA says Amor Nino Foods' ready-to-eat Hawaiian-style aku tuna sticks were made under an inadequate seafood safety plan and without required monitoring.

    High risk
  38. Cosmax NBT USA

    FDA warned Cosmax NBT USA that its dietary supplement manufacturing and labeling violated federal rules.

    Medium
  39. Victory Trading Company Inc.

    FDA warns Victory Trading after finding widespread rodent infestation in its Greenland, NH food warehouse.

    High risk
  40. King Systems Corp. dba Ambu, Inc.

    FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.

    High risk
  41. K. Boeun Pharmaceutical Co., Ltd.

    K. Boeun Pharmaceutical's OTC drugs were cited for CGMP violations, including missing identity tests for DEG/EG-risk components and inadequate quality unit.

    High risk
  42. International Laboratories Corp. Ltd.

    International Laboratories Corp. Ltd. failed manufacturing-practice rules for OTC drugs, including component identity testing and quality-unit oversight.

    High risk
  43. Seafood Brothers Inc., DBA G & L Seafood Inc.

    FDA warned Seafood Brothers Inc. (G & L Seafood) that imported clams, anchovies, and tilapia lacked required seafood HACCP importer verification.

    High risk
  44. Sol-ti Inc.

    FDA found Sol-ti's ready-to-drink juices lacked validated pathogen controls and required safety monitoring.

    High risk
  45. CalmCo LLC previously named Ketomi LLC

    FDA warns CalmCo that Colic Calm and Colic Calm + are unapproved new drugs for infants.

    High risk
  46. ALVA-AMCO Pharmacal Companies, LLC

    FDA warns ALVA-AMCO that Nauzene Kids, a children’s nausea drug, is an unapproved new drug.

    High risk
  47. Laavo Clean, S.A. de C.V.

    Laavo Clean's alcohol-free hand sanitizers had wrong benzalkonium chloride strength and were refused at US border.

    High risk
  48. Denison Pharmaceuticals, LLC

    Denison Pharmaceuticals was cited for manufacturing quality failures, contamination risks, and unapproved infant/homeopathic drugs.

    High risk
  49. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.

    High risk
  50. STPCA Inc. dba Sun Ten Laboratories

    FDA: Sun Ten Laboratories sold herbal products as unapproved drugs and broke supplement manufacturing rules at its Irvine, California plant.

    High risk